sub:assertion {
  d:DB00724 v:identifier "DB00724" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00724" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00724> ;
    dv:drugbank-id "APRD01030" , "DB00724" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:84:92.00> ;
    dv:x-atc <http://bio2rdf.org/atc:D06BB10> ;
    dv:x-cas <http://bio2rdf.org/cas:99011-02-6> ;
    dv:x-chebi <http://bio2rdf.org/chebi:36704> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:51809> ;
    dv:x-dpd <http://bio2rdf.org/dpd:2239505> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D02500> ;
    dv:x-ndc <http://bio2rdf.org/ndc:0168-0432-24> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA449972> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:57469> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46505394> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Imiquimod> ;
    dct:description "Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. Miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin cancer called superficial basal cell carcinoma."@en ;
    dct:identifier "drugbank:DB00724" ;
    dct:title "Imiquimod"@en ;
    a dv:Drug ;
    rdfs:label "Imiquimod [drugbank:DB00724]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00724> , <http://www.drugs.com/cdi/imiquimod.html> , <http://www.rxlist.com/cgi/generic/imiquimod.htm> .
}